X
Marwadi Group TV Advt
INQUIRY FOR NEW ACCOUNT FOLLOW US ON
Stock Info
(Sensex : 29918.40, -111.34 Pts) << Prices as on 28 Apr, 2017 >>Adani Ports &Special  : 326.90  [ 1.25 % ]Asian Paints  : 1119.60  [ 1.54 % ]Axis Bank  : 509.60  [ 0.72 % ]Bajaj Auto  : 2868.35  [ 0.27 % ]Bharti Airtel  : 354.60  [ -0.94 % ]Cipla  : 556.80  [ -0.73 % ]Coal India  : 276.85  [ 0.80 % ]Dr. Reddys Lab  : 2599.15  [ 0.23 % ]GAIL India  : 423.75  [ 1.23 % ]HDFC  : 1537.05  [ -1.93 % ]HDFC Bank  : 1542.15  [ -1.60 % ]Hero MotoCorp  : 3310.70  [ 0.41 % ]Hindustan Unilever  : 934.70  [ -1.23 % ]ICICI Bank  : 278.50  [ 1.62 % ]Infosys  : 919.40  [ -0.49 % ]ITC  : 278.60  [ -2.28 % ]Larsen & Toubro  : 1748.05  [ -0.85 % ]Lupin  : 1337.80  [ 0.04 % ]Mahindra & Mahindra  : 1334.55  [ -0.26 % ]Maruti Suzuki  : 6525.50  [ 2.42 % ]NTPC  : 164.40  [ 0.03 % ]ONGC  : 186.30  [ 3.76 % ]Power Grid Corpn.  : 207.60  [ 0.17 % ]Reliance Industries  : 1394.80  [ -0.94 % ]SBI  : 289.45  [ 2.66 % ]Sun Pharma Inds.  : 642.55  [ 0.88 % ]Tata Motors  : 457.80  [ 0.41 % ]Tata Steel  : 448.85  [ 0.70 % ]TCS  : 2272.10  [ -1.27 % ]Wipro  : 494.10  [ -0.32 % ]
Company Profile
Company Profile
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Share Price
MF Holdings
Price Charts
Company News
CompanyChart
Cash Flow
Share Holdings
Deliverable Volume
Historical Volume
Digital Reports
Peer Comparison
Board Meetings
Corporate Announcements
Book Closure
Bonus Issues
AGM
You Are On: Home| Markets | Company Profile | Board Meetings
Board Meetings
Sun Pharmaceutical Industries Ltd.
 
Source DateBoard Meeting Date    Details
31-Jan-2017 14-Feb-2017 Quarterly Results
25-Oct-2016 10-Nov-2016 Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 10, 2016, inter alia, to transact the following business: 1. To consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2016 (Q2). 2. To consider the proposal for the merger/amalgamation of Ranbaxy Drugs Limited, Vidyut Investments Limited, Gufic Pharma Limited and Sun Pharma Medisales Private Limited (formerly known as Solrex Pharmaceutical Company), all four companies being wholly owned subsidiaries of Sun Pharmaceutical Industries Ltd., with Sun Pharmaceutical Industries Ltd subject to receipt of necessary approvals. & Quarterly Results
02-Aug-2016 12-Aug-2016 Quarterly Results
16-May-2016 30-May-2016 Audited Results & Dividend
28-Jan-2016 12-Feb-2016 Quarterly Results
23-Oct-2015 07-Nov-2015 Quarterly Results
04-Aug-2015 11-Aug-2015 With reference to earlier announcement regarding Q1 results on August 11, 2015, Company has now informed BSE that the Board of Directors of the Company at its meeting scheduled to be held on August 11, 201 5 would also transact the following business: 1. Consideration of the revised audited annual accounts of the Company for the year ended March 31, 2015 after giving the effect to the Scheme of Amalgamation of SPGI into SPIL and the proposal for payment of dividend. 2. Consideration of the recommendation of payment of dividend on equity shares for the year ended March 31, 2015 subject to the approval of the shareholders at the ensuing Annual General Meeting. & Dividend
28-Jul-2015 11-Aug-2015 With reference to earlier announcement regarding Q1 results on August 11, 2015, Company has now informed BSE that the Board of Directors of the Company at its meeting scheduled to be held on August 11, 201 5 would also transact the following business: 1. Consideration of the revised audited annual accounts of the Company for the year ended March 31, 2015 after giving the effect to the Scheme of Amalgamation of SPGI into SPIL and the proposal for payment of dividend. 2. Consideration of the recommendation of payment of dividend on equity shares for the year ended March 31, 2015 subject to the approval of the shareholders at the ensuing Annual General Meeting. & Dividend
14-May-2015 29-May-2015 Audited Results
29-Jan-2015 14-Feb-2015 Quarterly Results
29-Oct-2014 13-Nov-2014 Quarterly Results
30-Jul-2014 12-Aug-2014 Quarterly Results & BSE that the Hon'ble High Court of Gujarat, at Ahmedabad at its hearing held on July 10, 2014 has approved the Scheme of Arrangement and Reconstruction between Sun Pharmaceutical Industries Limited (SPIL) and Bun Pharma Global FZE (SPGFZE) in the nature of demerger and transfer of the specified Undertaking of SPGFZE to SPIL with effect from the appointed date of May 01, 2013. This is to further inform that the certified copy of the High Court order is expected to be received shortly and will be filed with the Registrar of Companies there after as required and the demerger process would get completed on such filing. 2. The Board of Directors of the Company would meet on August 12, 2014 to transact, inter alia, the following business. i) Consider the revised audited annual accounts of the Company for the year ended March 31, 2014 after giving the effect to the above mentioned Scheme of Arrangement and Reconstruction between SPIL and SPGFZE. (ii) To consider the recommendation of payment of dividend on equity shares for the year ended March 31, 2014 subject to the approval of the shareholders at the ensuing Annual General Meeting. (iii) To consider and take on record the un-audited financial results of the Company for the first quarter ended June 30, 2014 (Q1). 3. The window closure for Trading by Designated persons as per Insider Trading Rules of the Company will be from August 01, 2014 to August 14, 2014 (both days inclusive). & Dividend
16-May-2014 29-May-2014 Audited Results
27-Jan-2014 13-Feb-2014 Quarterly Results
28-Oct-2013 13-Nov-2013 Quarterly Results
24-Jul-2013 09-Aug-2013 Quarterly Results
14-May-2013 28-May-2013 Audited Results & Dividend
23-Jan-2013 08-Feb-2013 Quarterly Results
22-Oct-2012 08-Nov-2012 Quarterly Results
30-Jul-2012 10-Aug-2012 Quarterly Results
Page 1 of 4
Prev || Next

Attention Investors:

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Attention Investors:

"Prevent Unauthorized Transactions in your account --> Update your Mobile Numbers/email IDs with your stock brokers. Receive information of your transactions directly from exchange on your mobile/email at the end of the day..... issued in the interest of investors." "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day..... issued in the interest of investors. "

Attention Investors:

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Risk Disclosure | Sitemap | Disclaimer | Privacy Policy | Escalation | Terms of Use |
Research SMS Disclaimer Form | Investor Complaints| Investor Protection
Useful links:> SEBI | NSE | BSE | NSDL |CDSL | MCX | NCDEX | RBI | IRDA | AMFI | MSEI |
  Best viewed with 1024x768 resolution in IE 7 and above
MARWADI GROUP: SEBI REG. NO. MSFL (NSE INB/INF/ INE 230876034, BSE INB/INF/010876036,
BSE-CDS – EXCHANGED Registered, MSEI INB/INF 260876033 and INE 260876034, RESEARCH ANALYST : INH 000002186, MERCHANT BANKING : INM 000012235,
NSDL IN-DP-NSDL-98-99 CDSL IN-DP-CDSL-256-2004, PMS INP000001280, AMFI ARN-42506),
MCBPL (MCX 10305, FMC NO. MCX-MCX/TCM/CORP/0674,
NCDEX 00087, FMC NO. NCDEX-NCDEX/TCM/CORP/0025, NSEL 12850, ACE 6171)
CIN of MSFL : U65910GJ1992PLC017544, CIN of MCBPL : U74992GJ2001PTC040221
© Copyright 2010-2011 Marwadi Group All rights Reserved. Designed, Developed & Content Provided By Accord Fintech Pvt. Ltd